SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BioRestorative Therapies, Inc. (BRTX) (CIK 0001505497) (BRTX) — Oct 19, 2012

BioRestorative Therapies, Inc. (BRTX) (CIK 0001505497)
Date: Oct. 19, 2012 · CIK: 0001505497 · Accession: 0000000000-12-057891

Regulatory Compliance Financial Reporting Internal Controls

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-54402

Date
October 19, 2012
Author
/s/ David Link for
Form
UPLOAD
Company
BioRestorative Therapies, Inc. (BRTX) (CIK 0001505497)

Letter

October 19, 2012 Via E -mail Mark Weinreb Chief Executive Officer BioRestorative Therapies, Inc. 555 Heritage Drive Jupiter, Florida 33458

Re: BioRestorative Therapies, Inc. Preliminary Proxy Statement on Schedule 14A Filed October 5, 2012 File No. 000-54402

Dear Mr. Weinreb :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filin g and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the d isclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ David Link for

Show Raw Text
October  19, 2012

Via E -mail
Mark Weinreb
Chief Executive Officer
BioRestorative Therapies, Inc.
555 Heritage Drive
Jupiter, Florida  33458

Re: BioRestorative Therapies, Inc.
Preliminary Proxy  Statement on Schedule 14A
Filed October 5, 2012
  File No. 000-54402

Dear Mr. Weinreb :

We have completed our review of your filing.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filin g and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the d isclosure in the filing to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ David Link for

John Reynolds
Assistant Director

cc: Fred Skolnik, Esq.
Certilman Balin Adler &  Hyman, LL